Uptake of Heterologous or Homologous COVID-19 Booster Dose and Related Adverse Events Among Diabetic Patients: A Multicenter Cross-Sectional Study

Uptake of Heterologous or Homologous COVID-19 Booster Dose and Related Adverse Events Among Diabetic Patients: A Multicenter Cross-Sectional Study — China, 2022

Published:2023 Issue:1 Volume:5 Page:5-10
ISSN:2096-7071
Container-title:China CDC Weekly
language:en
Short-container-title:

Author:

Zhang Fan, ,Zhu Yaxin,He Zhong,Lan Xinquan,Song Moxin,Chen Xi,Li Mufan,Yang Jianzhou,Xu Junjie, , , , ,

Publisher

Chinese Center for Disease Control and Prevention

Subject

Public Health, Environmental and Occupational Health,Infectious Diseases,Epidemiology

Link

https://weekly.chinacdc.cn/en/article/pdf/preview/10.46234/ccdcw2023.002

Reference12 articles.

1. Powers AC, Aronoff DM, Eckel RH. COVID-19 vaccine prioritisation for type 1 and type 2 diabetes. Lancet Diabetes Endocrinol 2021;9(3):140 − 1. http://dx.doi.org/10.1016/S2213-8587(21)00017-6.

2. CDC. Evidence to recommendation framework: Pfizer-BioNTech COVID-19 Booster Dose. 2021. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-10-20-21/11-COVID-Dooling-508.pdf. [2021-10-20].

3. Duan LR, Wang Y, Dong HY, Song CY, Zheng JP, Li J, et al. The COVID-19 vaccination behavior and correlates in diabetic patients: a health belief model theory-based cross-sectional study in China, 2021. Vaccines 2022;10(5):659. http://dx.doi.org/10.3390/vaccines10050659.

4. Scoccimarro D, Panichi L, Ragghianti B, Silverii A, Mannucci E, Monami M. Sars-CoV2 vaccine hesitancy in Italy: a survey on subjects with diabetes. Nutr Metabol Cardiovasc Dis 2021;31(11):3243 − 6. http://dx.doi.org/10.1016/j.numecd.2021.09.002.

5. Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 2020;8(6):546 − 50. http://dx.doi.org/10.1016/S2213-8587(20)30152-2.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines;Drugs;2024-04